Government ❯ Regulatory Agencies ❯ Securities and Exchange Commission

FDA

Environmental Protection Agency Compliance Issues Corporate Compliance Drug Approval Process Compliance

Law Firms Urge Telix Investors To Seek Lead Role by Jan. 9 in Securities Class Action

Investors have until January 9, 2026 to move for lead‑plaintiff status in the Southern District of Indiana case.

Telix Class Action Seeks Losses After SEC Subpoena and FDA CRL Disclosures

Telix Securities Class Action Draws Flurry of Investor Notices Ahead of Lead-Plaintiff Deadline